Skip to content
KO·EN
Contact

DRAFT TRANSLATION · REVIEW PENDING

R&D CENTER

RESEARCH & DEVELOPMENT · HAEPAGEN

01Core TechnologyCORE TECHNOLOGY02R&D CenterR&D CENTER03Production InfrastructurePRODUCTION INFRASTRUCTURE04PatentsPATENTS

R&D CENTER

Next-generation atelocollagen biotechnology redefining the value of marine resources

HAEPAGEN R&D Center researches a biotechnology platform spanning skin regeneration, inner beauty and regenerative medicine based on ultra-pure atelocollagen core technology.

01 · RESEARCH DIRECTION

Three research directions from one core biomaterial

01

High-Purity Atelocollagen

Research into high-purity atelocollagen purification designed to minimize immune response.

02

Biomaterial Engineering

Research into structure, physical properties, stability and formulation potential.

03

Regenerative Applications

Exploring applications in skin, tissue and regenerative biomaterials.

02 · STRATEGIC R&D ALLIANCES

Advancing technical maturity with specialist research institutes

Joint research networks support studies of purification mechanisms, biocompatibility and material stability.

GISTGwangju Institute of Science and Technology
  • High-purity atelocollagen purification mechanisms
  • Structural analysis of effective materials
  • Skin cell regeneration research
  • Joint biocompatibility validation research
KAERIKorea Atomic Energy Research Institute
  • Radiation and electron-beam processing technology
  • Molecular cross-linking research for biomaterials
  • Hydrogel research
  • Collaboration on physical and chemical stability for regenerative biomaterials

03 · R&D PIPELINE

Research foundations that connect with future business applications

01
DERMA RESEARCH

Cosmetics / Derma

Skin barrier strengthening and cell regeneration solutions

02
INNER BEAUTY RESEARCH

Nutraceuticals

High-absorption inner beauty formulation technology

03
REGENERATIVE RESEARCH

Regenerative Medicine

Tissue regeneration and medical biomaterials

Explore Business Applications→
HAEPAGEN

English corporate copy is awaiting content approval.

Contact →
COMPANYCEO MESSAGE
R&DCORE TECHNOLOGYPRODUCTION INFRASTRUCTUREPATENTS
BUSINESS
ESG
IRGLOBAL RESOURCES
PR